Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |